Andrographolide enhances cisplatin-mediated anticancer effects in lung cancer cells through blockade of autophagy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Anti-Cancer Drugs

• Publication date

  2017-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/CAD.0000000000000537PMID 28692436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autophagy and cancer therapy cardiotoxicity: From molecular mechanisms to therapeutic opportunities.

  2020cited by this paper
• An Integrative View of Cisplatin Uptake by Kidney and Renal Toxicity

  2018cited by this paper
• Suppressor of cytokine signaling 3 modulates transforming growth factor-β signaling in human chondrocytes through the inhibition of the JAK/STAT3 pathway

  2018cited by this paper
• Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors

  2016cited by this paper
• SLC27A4 regulate ATG4B activity and control reactions to chemotherapeutics-induced autophagy in human lung cancer cells

  2016cited by this paper
• Inhibition of autophagy by andrographolide resensitizes cisplatin-resistant non-small cell lung carcinoma cells via activation of the Akt/mTOR pathway.

  2016cited by this paper
• An integrative view of cisplatin-induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures.

  2016cited by this paper
• Andrographolide and analogues in cancer prevention.

  2015cited by this paper
• Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells

  2015cited by this paper
• Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance

  2015cited by this paper
• GMI, an Immunomodulatory Protein from Ganoderma microsporum, Potentiates Cisplatin-Induced Apoptosis via Autophagy in Lung Cancer Cells.

  2015cited by this paper
• Andrographolide decreased VEGFD expression in hepatoma cancer cells by inducing ubiquitin/proteasome-mediated cFos protein degradation.

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer

  2014cited by this paper
• Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.

  2014cited by this paper
• Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.

  2013cited by this paper
• Management of non-small-cell lung cancer: recent developments.

  2013cited by this paper
• Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cells

  2012cited by this paper
• Autophagy induction by low-dose cisplatin: the role of p53 in autophagy.

  2012cited by this paper
• Long-term cisplatin exposure impairs autophagy and causes cisplatin resistance in human lung cancer cells

  2012cited by this paper
• Suppression of basal autophagy reduces lung cancer cell proliferation and enhances caspase-dependent and -independent apoptosis by stimulating ROS formation

  2012cited by this paper
• Inhibition of autophagy by TAB2 and TAB3

  2011cited by this paper
• Autophagy and cancer therapy

  2011cited by this paper
• Autophagy as a therapeutic target in cancer

  2011cited by this paper
• Methods in mammalian autophagy research.

  2010cited by this paper
• Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin.

  2010cited by this paper
• Mitochondrial-Mediated Apoptosis in Lymphoma Cells by the Diterpenoid Lactone Andrographolide, the Active Component of Andrographis paniculata

  2010cited by this paper
• Neuroprotective effects of andrographolide in a rat model of permanent cerebral ischaemia

  2010cited by this paper
• In vitro and in vivo anti-inflammatory effects of andrographolide.

  2009cited by this paper
• Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells.

  2009cited by this paper
• Phosphatidylinositol 3‐kinase inhibitors: promising drug candidates for cancer therapy

  2008cited by this paper
• UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers

  2008cited by this paper
• Chemically targeting the PI3K family.

  2007cited by this paper
• Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.

  2007cited by this paper
• Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials

  2004cited by this paper

• Andrographolide reverses lung cancer cisplatin resistance by targeting CDK1: A network pharmacology and experimental study

  2025cites this paper
• Traditional Chinese medicine in lung cancer treatment

  2025cites this paper
• Antitumor activity of gamma-irradiated Rosa canina L. against lung carcinoma in rat model: a proposed mechanism

  2025cites this paper
• Lysosomes and LAMPs as Autophagy Drivers of Drug Resistance in Colorectal Cancer

  2025cites this paper
• Immunotherapy in Neuroblastoma: Mini-Review of Novel Directions and Challenges.

  2025cites this paper
• Targeting autophagy can synergize the efficacy of immune checkpoint inhibitors against therapeutic resistance: New promising strategy to reinvigorate cancer therapy

  2024cites this paper
• The therapeutic potential of andrographolide in cancer treatment.

  2024cites this paper
• Andrographolide acts with dexamethasone to inhibit the growth of acute lymphoblastic leukemia CEM‑C1 cells via the regulation of the autophagy‑dependent PI3K/AKT/mTOR signaling pathway

  2024cites this paper
• Andrographis modulates cisplatin resistance in lung cancer via miR-155-5p/SIRT1 axis

  2023cites this paper
• Anti-Cancer Agent: The Labdane Diterpenoid-Andrographolide

  2023cites this paper
• Insight into autophagy in platinum resistance of cancer

  2023cites this paper
• Research Progress and Prospects of Autophagy in the Mechanism of Multidrug Resistance in Tumors

  2022cites this paper
• Synthesis and anticancer activity evaluation of 7-oxygen-substituted and 8,17-Epoxydized 1,2-Didehydro-3-Ox-14-Deoxyandrographolide derivatives.

  2022cites this paper
• Focusing on the Role of Natural Products in Overcoming Cancer Drug Resistance: An Autophagy-Based Perspective

  2022cites this paper
• Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: A review.

  2022cites this paper
• AZGP1 Up-Regulation is a Potential Target for Andrographolide Reversing Radioresistance of Colorectal Cancer

  2022cites this paper
• AZGP1 Up-Regulation is a Potential Target for Andrographolide Reversing Radioresistance of Colorectal Cancer

  2022cites this paper
• Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy

  2022cites this paper
• The Effect of Terpenoid Natural Chinese Medicine Molecular Compound on Lung Cancer Treatment

  2021cites this paper
• Synergistic potential of dual andrographolide and melatonin targeting of metastatic colon cancer cells: Using the Chou-Talalay combination index method.

  2021cites this paper
• Andrographolide Against Lung Cancer-New Pharmacological Insights Based on High-Throughput Metabolomics Analysis Combined with Network Pharmacology

  2021cites this paper
• Andrographolide and its derivatives: Current achievements and future perspectives.

  2021cites this paper
• Andrographolide inhibits non-small cell lung cancer cell proliferation through the activation of the mitochondrial apoptosis pathway and by reprogramming host glucose metabolism

  2021cites this paper
• Advances in ameliorating inflammatory diseases and cancers by andrographolide: Pharmacokinetics, pharmacodynamics, and perspective

  2021cites this paper
• LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells by Targeting the miR-200a/β-Catenin Pathway

  2020cites this paper
• CMAR_A_240695 2001..2014

  2020cites this paper
• Andrographolide a potential therapeutic drug against breast cancer: A review

  2020cites this paper
• The effects of carvedilol, metoprolol and propranolol on cisplatin-induced kidney injury

  2020cites this paper
• Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer

  2020cites this paper
• Low-dose angiotensin AT1 receptor β-arrestin-biased ligand, TRV027, protects against cisplatin-induced nephrotoxicity

  2020cites this paper
• Andrographolide attenuates epithelial‐mesenchymal transition induced by TGF‐β1 in alveolar epithelial cells

  2020cites this paper
• Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19

  2020cites this paper
• Phytochemicals: Current strategy to sensitize cancer cells to cisplatin.

  2019cites this paper
• Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy

  2019cites this paper
• Synergistic Effects of Andrographolide on DNA Damage Repair Mechanism and Apoptosis in Breast Cancer Cells

  2019cites this paper
• Andrographolide sensitizes Hep-2 human laryngeal cancer cells to carboplatin-induced apoptosis by increasing reactive oxygen species levels.

  2019cites this paper
• Andrographolide Protects PC12 Cells Against β-Amyloid-Induced Autophagy-Associated Cell Death Through Activation of the Nrf2-Mediated p62 Signaling Pathway

  2018cites this paper